On Investors' Radar: Cantor Fitzgerald's $70 "BUY" Recommendation for Nanox
As the economy begins to reverse course amid the stock market's lackluster performance during the pandemic, it is time for investors to review which start-up and leading companies to finance in the next year. With 2021 bringing the promises of market increases, one of the leading financial firms recommends investors to put Nanox's ground-breaking product on their radar with a $70 target.
Cantor Fitzgerald endorsed Nanox at RSNA Virtual Meeting 2020
On December 3, investors and businesses attended the 2020 Radiological Society of North America (RSNA) Virtual Annual Meeting, which held a live demonstration of upcoming innovative products. Attended by 11,000 international participants, the event featured real-time commentary by radiology and medical experts. Following the event, Cantor Fitzgerald firm endorsed Nanox Imaging Ltd. (NASDAQ: NNOX), an Israel-Japanese medical imaging company established by Ran Poliakine.
Cantor Fitzgerald is one of the prestigious financial services companies
Cantor Fitzgerald, a major US investment banking firm, which was founded over 75 years ago, is considered one of the most prestigious financial services companies globally. Their endorsement includes an impressive target BUY recommendation of $70 per share rate in their backing of Nanox. This full-throated affirmation of the Israeli-Japanese company gives investors' and other financial institutions confidence to support Nanox's groundbreaking product.
Nanox's innovative X-ray tube is made with ceramic coating
Nanox's new X-ray imaging technology is a vital new development to the medical field in order to make medical imaging more affordable and accessible throughout the global market. Nanox's innovative X-ray tube is made with ceramic coating and costs $100 per unit compared to some market X-ray tubes made of glass, which can cost as much as $150,000 per unit.
Nanox is now bringing X-rays into the digital age
While X-rays have not been fundamentally improved since their inception in 1895, Nanox is now bringing X-rays into the digital age. Their digital technology allows for an industry-wide evaluation, so a strain of medical imaging can provide patients quicker and most cost-effective service.
This invention addresses the unmet challenges in digital medical imaging
The RSNA Virtual Annual Meeting's webinar broadcasted the significant recorded live stream of the clinical application of the Nanox.ARC system. Many experts in the radiological field believe that the invention will be able to address the unmet challenges in the field of digital medical imaging. American and international media have reported widely about the event and on Nanox's system during the live demonstration.
Nanox's stock potentials and media recognition have increased all around
Currently, Nanox's stock potentials have increased all around and are garnering major media recognition for their innovative technology. Since the event, the company's commercial team has reportedly received hundreds of requests and interest from a plethora of sources across the industry.
Expect Nanox to install 15,000 units by 2024: Cantor Fitzgerald
Nanox is expected to start exporting shipments in the third and fourth quarters of 2021, with 15,000 planned units to be transported by 2024. According to Cantor Fitzgerald, "We remain enthusiastic toward the company's long-term growth potential and continue to expect the company to install 15,000 units by 2024 and for peak revenue to reach about $900 million in 2026."
